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Research
Diabetes is one of the most prevalent chronic
diseases in developed countries, conferring a
signiﬁcant burden in terms of medical com-
plications and health-care costs. Between
1980 and 2004, the number of Americans
with diabetes increased from 5.8 million to
14.7 million. In 2004 alone, there were
approximately 1.4 million new diagnoses of
diabetes in American adults (18–79 years of
age) [Centers for Disease Control and
Prevention (CDC) 2005]. Incidence and
prevalence of diabetes vary by age, ethnicity,
and socioeconomic factors and are, in general,
higher in Native Americans (CDC 2003a).
Known risk factors for diabetes include obe-
sity, genetic susceptibility, hyperinsulinemia
(a marker for insulin resistance), sedentary
lifestyle (Warram and Krolewski 2005), and
cigarette smoking (Rimm et al. 1995; Will
et al. 2001).
Polychlorinated biphenyls (PCBs) were
produced for use in various industries until
the late 1970s when their production was
banned. By then, large quantities of PCBs
had been released into the environment.
They are persistent substances both in the
environment and in biota, and they bio-
accumulate and biomagnify in the food
chain. Once in the human body they persist
for long periods, accumulating in adipose
tissue and in the lipid component of serum.
The Mohawk Nation at Akwesasne is a
Native American population residing along
the St. Lawrence River that separates New
York State from Ontario and Quebec
(Canada). Mohawks are traditionally a fish-
eating community. There are three aluminum
foundries just upriver from the reservation,
namely the General Motors Central Foundry
Division (a National Priority List site) and
plants operated by Reynolds Metal and the
Aluminum Company of America (ALCOA)
(Hwang et al. 1993). PCBs (primarily Aroclor
1248) were used as hydraulic ﬂuids at all three
facilities. PCBs that leaked were washed into
the St. Lawrence River and its tributaries. Via
the air, soil, and water, PCBs contaminated
the environment and local flora and fauna,
and entered the food chain. Although they are
only modestly elevated, PCB levels in
Mohawk breast milk (Hwang et al. 1996) and
serum (Fitzgerald et al. 2004) have been cor-
related with rates of consumption of local ﬁsh,
even though ﬁsh consumption has declined in
recent years after issuance of advisories.
Recent studies have reported an associa-
tion between exposure to organochlorines
and impaired blood-glucose regulation and
diabetes. Several epidemiologic studies
(Calvert et al. 1999; Pesatori et al. 1998;
Vena et al. 1998) have shown that dioxin
exposure is associated with elevated rates of
diabetes and dysglycemia. U.S. Air Force vet-
erans of Operation Ranch Hand, who
applied Agent Orange in Vietnam, were
exposed to dioxin. Exposure was associated
with an elevated incidence of diabetes and
was inversely associated with the length of
time to diabetes onset (Henriksen et al.
1997). Cranmer et al. (2000) reported that
dioxin exposure resulted in hyperinsulinemia
and insulin resistance, and Fierens et al.
(2003) reported signiﬁcant odds ratios (ORs)
of 5.1, 13.3, and 7.6 for risk of diabetes in
relation to top decile concentrations of diox-
ins, coplanar PCBs, and 12 PCB markers.
Longnecker et al. (2001) reported that preg-
nant women with diabetes had higher PCB
levels than did nondiabetic pregnant women.
Radikova et al. (2004) reported that PCB
concentrations in a Slovak population were
associated with elevated levels of blood 
glucose. Vasiliu et al. (2006) found a linear
association between PCB serum levels and
diabetes incidence in a large cohort in
Michigan, and Lee et al. (2006) found a
Address correspondence to D.O. Carpenter, Institute
for Health and the Environment, University at
Albany, 5 University Place, A217, Rensselaer, NY
12144-3429 USA. Telephone: (518) 525-2660. Fax:
(518) 525-2665. E-mail: Carpent@uamail.albany.edu
We thank A. DeCaprio, L. Hubicki, C.S. Norton-
Wenzel, and B. Wells for assistance.
This study was supported in part by the Fogarty
International Center (grant TW00636 to D.O.C.),
the National Institute of Environmental Health
Sciences (grant ES04913 to D.O.C.), and the Institute
for Health and the Environment, University at
Albany. 
The authors declare they have no competing
ﬁnancial interests.
Received 29 March 2007; accepted 17 July 2007.
Diabetes in Relation to Serum Levels of Polychlorinated Biphenyls and
Chlorinated Pesticides in Adult Native Americans
Neculai Codru,1 Maria J. Schymura,1,2 Serban Negoita,1,2 The Akwesasne Task Force on the Environment,3
Robert Rej,4,5 and David O. Carpenter 6
1Department of Epidemiology and Statistics, School of Public Health, University at Albany, Rensselaer, New York, USA; 2New York State
Department of Health, Albany, New York, USA; 3Mohawk Nation at Akwesasne, Hogansburg, New York, USA; 4Wadsworth Center,
New York State Department of Health, Albany, New York, USA; 5Department of Biomedical Sciences, School of Public Health, University
at Albany, Albany, New York, USA; 6Institute for Health and the Environment, University at Albany, Rensselaer, New York, USA 
BACKGROUND: Recent research suggests that diabetes, a condition whose incidence is increasing, is
associated with exposure to polychlorinated biphenyls (PCBs) and chlorinated pesticides.
OBJECTIVES: We investigated the potential association between diabetes and serum levels of PCBs,
dichlorodiphenyldichloroethylene (DDE), hexachlorobenzene (HCB), and mirex in a cross-sectional
study of an adult Native-American (Mohawk) population.
METHODS: Through a standardized questionnaire we collected demographic, medical, and lifestyle
information from 352 adults, ≥ 30 years of age. We collected fasting serum samples that were ana-
lyzed for 101 PCB congeners, DDE, HCB, and mirex along with fasting glucose, triglycerides,
and cholesterol. Participants who had fasting-glucose values > 125 mg/dL and/or who were taking
antidiabetic medication were deﬁned as persons with diabetes. We conducted logistic regression to
assess the potential association between organochlorine serum levels and diabetes, while control-
ling for the potential confounding variables of age, body mass index (BMI), smoking, sex, and
serum lipid levels. Organochlorine serum levels were categorized in tertiles, and the lowest tertile
was used as the reference category.
RESULTS: The prevalence of diabetes was 20.2%. The odds ratio (OR) of having diabetes for partic-
ipants in the highest tertile of total PCB concentration compared with the lowest tertile was 3.9
(95% conﬁdence interval, 1.5–10.6). The corresponding ORs for DDE and HCB were even higher.
Elevated serum mirex was not associated with diabetes. After adjustment for other analytes, the OR
for HCB remained signiﬁcant, whereas ORs for PCBs and DDE remained elevated but not statisti-
cally signiﬁcant. In contrast, after adjustment for other analytes, the OR for mirex became statisti-
cally signiﬁcant and indicated an inverse association.
CONCLUSIONS: In this study of adult Native Americans, elevated serum PCBs, DDE, and HCB
were positively associated with diabetes after controlling for potential confounders, whereas a
negative association was observed for mirex.
KEY WORDS: BMI, DDE, fasting glucose, hexachlorobenzene, mirex, polychlorinated biphenyls.
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http://dx.doi.org/ [Online 17 July 2007]strong dose–response relationship between
serum concentrations of six persistent organic
pollutants [PCB-153, two dioxin congeners,
oxychlordane, dichlorodiphenyldichloroeth-
ylene (DDE), and trans-nonachlor] and dia-
betes. Everett et al. (2006) reported an
association between serum levels of both
PCB-126 (a dioxin-like PCB) and p,p´-DDT
(dichlorodiphenyltrichloroethane). DDE, the
major metabolite of DDT, has previously
been reported to be associated with diabetes
(Glynn et al. 2003; Rylander et al. 2005),
and hexachlorobenzene (HCB) was also
linked to diabetes in cross-sectional studies
(Glynn et al. 2003). Lee et al. (2007) have
expanded their study to analyze the data from
the sum of four dioxin-like PCB congeners
and ﬁve nondioxin-like congeners, and report
that the dioxin-like congeners showed the
strongest relationship with diabetes.
The present study was designed to inves-
tigate whether a relationship exists between
diabetes and serum levels of total PCBs, two
single PCB congeners, and the chlorinated
pesticides DDE, HCB, and mirex in adult
Mohawks.
Materials and Methods
Mohawk adults ≥ 30 years of age who resided
at or near Akwesasne for at least 5 years were
eligible for this study. Recruitment took place
between 1995 and 2000, and sampling was
performed on a household basis. A listing of
all households was constructed by Mohawk
ﬁeld staff with the aid of detailed maps of the
reserve. Staff members drove through assigned
sections of the reserve and systematically
reviewed all structures and cataloged housing
units. Multiple-family dwelling units were
subdivided into individual households.
Known Mohawk housing units in the vicinity
of Akwesasne but off the reservation were
added to the list. Once this list was com-
pleted, a simple random sample of households
was selected. Selected households were visited
by project staff, who determined the composi-
tion of the household and study eligibility.
One eligible adult per household was invited
to participate. We were able to ascertain
household composition for 68.1% of selected
households and enrolled 401 (65.3%) eligible
adults into the study. The ﬁnal study popula-
tion consisted of 352 participants for whom
we had all relevant blood measurements.
Written informed consent was obtained
from the participants. All participants were
administered a core interview that included
demographic information and questions on
diet, residential and occupational exposures
and education. The standardized question-
naire, administered via an in-person inter-
view, included open-ended questions on
participants’ medical conditions and medica-
tions. Medication used in this population for
glucose regulation included glyburide
(34 participants), insulin and its analogues
(13 participants), metformin (18 partici-
pants), and troglitazone (2 participants).
Blood samples were obtained by venipunc-
ture between 0700 and 1030 hours after
overnight fasting in 5-mL collection tubes for
analysis of glucose, triglycerides, and choles-
terol and a separate sample (10 mL whole
blood for ~ 5 mL serum) for analysis of
101 PCB congeners, DDE, HCB, and mirex.
The blood samples were allowed to clot at
room temperature for 1 hr, then centrifuged
and the serum removed. Serum for both analy-
ses were then stored at –80°C on-site until
being transported on dry ice to the laboratories
for analysis.
Serum glucose and lipid concentrations
were measured in the New York State
Department of Health Laboratory (Wadsworth
Center) on a Hitachi 911 analyzer (Roche
Diagnostics, Indianapolis, IN) using the hexo-
kinase and glucose-6-phosphate dehydrogenase
coupled method for glucose (Kunst et al.
1984), and cholesterol esterase and oxidase, as
well as peroxidase for total cholesterol (Allain
et al. 1974). Triglycerides were determined by a
glycerol kinase-based procedure that corrects for
free glycerol in the specimen (Kohlmeier 1986),
as recommended by the National Cholesterol
Education Program Working Group on
Lipoprotein Measurement (Stein and Myers
1966). The facility is approved by the Clinical
Laboratory Improvement Amendments and is
a member of the CDC reference laboratory net-
work for lipid measurements (Myers et al.
2000). Total serum lipids were calculated using
the “short” formula proposed by Phillips et al.
(1989) and recently validated by the same
group (Bernert et al. 2007): Total lipids
(mg/dL) = 2.27 × total cholesterol (mg/dL) +
triglycerides (mg/dL) + 62.3.
PCB analysis was performed in the
Exposure Assessment Laboratory of the
University at Albany as described by DeCaprio
et al. (2000). The ultratrace analytical methods
used dual-column gas chromatography with
electron-capture detection to measure 92 ana-
lytical peaks that represent 83 single PCB con-
geners and 18 congeners as pairs or triplets, for
a total of 101 PCB congeners, plus DDE,
mirex, and HCB. Results are reported as both
wet weight and lipid-based values. Lipid-based
values were determined by dividing the wet
weight value by total serum lipids as calculated
above and then multiplying by a factor of 105
for unit adjustment (nanograms of toxicant per
gram lipid). Values below the method detec-
tion limit (MDL) were set to zero.
Diabetes was deﬁned as having a fasting-
glucose value > 125 mg/dL [American
Diabetes Association (ADA) 2003a, 2007] or
taking physician-ordered antidiabetes medica-
tion. We included known risk factors, age,
obesity (indicated by the body mass index;
BMI), and smoking (deﬁned as a categorical
variable so that participants who smoked at
least 100 cigarettes over their lifetime were
classified as smokers and all others as non-
smokers). Age was included as a categorical
predictor, dichotomized at 45 years. We
chose 45 years for several reasons: 45 is the
recommended age to begin diabetes screening
(ADA 2003b); it is close to the median age
of our study population; and we found that
dichotomizing age at 45 years provided opti-
mal control for confounding. BMI (in kilo-
grams per square meter) was categorized as
proposed by the CDC (2005): < 25, 25–29.9
(corresponding to overweight), and ≥ 30
(corresponding to obesity). BMI < 25 was
the reference category.
To account for potential risk factors and
confounders (serum lipid levels, age, BMI,
sex, smoking history) we conducted logistic
regression. The outcome of interest was
dichotomous (yes/no). The decision to intro-
duce smoking in the analysis was based on the
fact that smoking is associated with both dia-
betes (as a risk factor) and toxicant values.
Deutch et al. (2003) reported that smoking
status was a determinant of the blood organo-
chlorine levels in Greenland natives. We also
considered sex to be a potential confounder
because of the differences in fat content, dis-
tribution, and modes of excretion (e.g., lacta-
tion in women) between the sexes. Therefore,
organochlorine dynamics may be different in
females than in males.
Statistical analysis. The association
between diabetes and established risk factors
was initially analyzed through bivariate analysis
of each factor separately. We also performed
bivariate analysis for the total PCBs, two indi-
vidual congeners, and three organochlorine
pesticides. The toxicants were grouped in ter-
tiles of exposure, with the lowest one serving as
the reference (comparison) group.
Logistic regression was used for all multi-
variable analyses. We ﬁrst estimated the asso-
ciation of diabetes with the serum wet-weight
concentration of total PCBs, PCB-153,
PCB-74, DDE, HCB, and mirex, one ana-
lyte at a time, while adjusting for age, sex,
BMI, smoking status, and estimated total
lipid concentration. We then measured the
association of total PCBs, DDE, mirex, and
HCB while simultaneously adjusting for all
analytes and the above-mentioned diabetes
risk factors. Subsequently, we measured the
association of diabetes with the serum con-
centration of PCB-153 and PCB-74 while
simultaneously adjusting for the serum con-
centration of the chlorinated pesticides and
diabetes risk factors. Finally, we replicated the
analyses using lipid-standardized concentra-
tion values. In the later models, all estimates
of association were adjusted for the diabetes
PCBs, pesticides, and diabetes
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concentration. All analyses were conducted
using SAS software (version 8.2, SAS Institute
Inc, Cary, NC).
Results
Tables 1 and 2 show the characteristics of the
final study population for whom all blood
measurements were available. These tables
present age, BMI, and fasting-glucose and
serum lipid levels as well as antidiabetes med-
ication. Women comprised almost 62% of
participants, and about three-fourths of the
participants were smokers. Seventy-one par-
ticipants (20.2%) were diabetic, according to
our criteria. All participants taking medica-
tion for glucose regulation also reported they
had been diagnosed with diabetes, although
some with elevated fasting-glucose levels were
not taking glucose regulatory medication.
Table 3 shows wet weight and lipid-
adjusted levels of total PCBs, two individual
PCB congeners (PCB-153 and PCB-74), and
the three pesticides, and gives the MDL and
percentage of samples above the MDL for the
PCB congeners and the pesticides. Also shown
are the minimum, 33%, 50%, 67%, and max-
imum values. Total wet weight serum PCB
levels ranged from 0.51 to 48.32 ppb; in 95%
of the subjects, the total PCB serum levels
were < 13 ppb. Lipid-adjusted total PCB val-
ues had a median level of 579.8 ng/g lipid
(range, 84.8–7110.1 ng/g lipid).
Table 4 presents results showing the associ-
ation between diabetes and total serum PCBs,
mirex, DDE, and HCB by tertile, adjusted for
sex, age, BMI, and smoking status. Also shown
are results after concurrent adjustment for each
of the other analytes. We observed a signiﬁcant
association for highest versus lowest tertile of
both wet weight (OR = 3.90) and lipid-based
(OR = 3.29) PCBs and diabetes, but this rela-
tionship was less after concurrent adjustment
for the pesticides. Mirex showed no relation-
ship with diabetes when other analytes were
not included in the model, but a statistically
signiﬁcant inverse association was observed at
the highest tertile after controlling for the other
analytes (OR = 0.3). There were statistically
signiﬁcant associations between diabetes and
both DDE (OR = 6.4) and HCB (OR = 6.2)
at the highest tertile. The relationship
remained statistically signiﬁcantly elevated for
HCB after adjustment for PCBs, mirex, and
DDE, whereas that for DDE remained ele-
vated but not signiﬁcant after adjustment for
other contaminants.
Table 4 also shows similar data for two
individual PCB congeners, PCB-153 [the con-
gener present in this population at the highest
concentration, and the single PCB congener
reported by Lee et al. (2006)], and PCB-74, a
mono-ortho congener previously reported to
be most closely related to rates of fish con-
sumption in this population (Fitzgerald et al.
2006). We found a signiﬁcantly increased risk
of diabetes in relation to the highest tertile
(compared with the lowest tertile) for lipid-
based PCB-153 and an even higher risk for
both wet weight and lipid-based PCB-74
when not adjusted for the levels of pesticides.
After concurrent adjustment for the pesticides,
the ORs were lower, and the OR for PCB-74
almost reached statistical signiﬁcance.
Discussion
Although diabetes has not usually been con-
sidered to be an environmentally induced dis-
ease, we have found a significant association
between serum PCB and pesticide levels and
diabetes in an adult Native-American popula-
tion after adjustment for age, BMI, serum
lipid levels, sex, and smoking. Although these
results do not establish cause and effect, there
is a growing body of evidence that environ-
mental exposure to persistent organochlorine
compounds is associated with elevated inci-
dence of this disease. Elevated incidence of
diabetes has been demonstrated following
dioxin exposure in Seveso, Italy (Bertazzi et al.
1998; Pesatori et al. 1998). Vena et al. (1998)
reported similar findings in a large study of
workers exposed to dioxins during production
of phenoxy herbicides and chlorophenol.
Cranmer et al. (2000) found that plasma
insulin concentrations were elevated in indi-
viduals who had elevated levels of dioxin, and
they concluded that dioxin exposure leads to
insulin resistance. The studies by Longnecker
et al. (2001), Radikova et al. (2004), and
Vasiliu et al. (2006) show dose-dependent rela-
tionships between diabetes or fasting-glucose
levels and PCBs. Kouznetsova et al. (2007)
reported elevated rates of hospitalization for
Codru et al.
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Table 3. Method detection limits (MDL) and the distribution of certain serum analyte concentrations before
and after lipid standardization.
Percentile
Analyte MDL % > MDL Mean ± SD Min 33rd 50th 67th Max
Wet-weight value (ppb)
Total PCBs NA NA 5.03 ± 4.29 0.51 2.80 3.87 5.28 48.32
PCB-153 0.02 99.7 0.70 ± 0.61 0.00 0.39 0.52 0.74 6.68
PCB-74 0.02 98.9 0.33 ± 0.43 0.00 0.12 0.19 0.28 4.79
Mirex 0.02 86.4 0.13 ± 0.16 0.00 0.05 0.08 0.13 1.67
DDE 0.02 100.0 3.64 ± 3.66 0.14 1.60 2.42 3.50 22.15
HCB 0.02 97.7 0.08 ± 0.04 0.00 0.06a 0.07 0.09 0.33
Lipid-standardized value (ng/g lipid)
Total PCBs NA NA 748.8 ± 635.6 84.8 448.6 579.8 756.2 7110.1
PCB-153 NA NA 104.5 ± 91.2 0.0 59.8 78.3 104.4 982.9
PCB-74 NA NA 49.0 ± 68.4 0.0 19.2 28.0 38.7 704.8
Mirex NA NA 19.2 ± 23.0 0.0 8.3 12.4 19.6 245.7
DDE NA NA 537.0 ± 512.6 20.3 246.1 349.5 544.6 3005.2
HCB NA NA 12.1 ± 6.5 0.0 9.1 11.1 13.0 61.9
Abbreviations: Max, maximum; Min, minimum; NA, not applicable. 
aHCB had a very narrow distribution among participants in this study; 30%, 41%, 55%, 64% and 72% had a concentration
≤ 0.05 ppb, 0.06 ppb, 0.07 ppb, 0.08 ppb, and 0.09 ppb, respectively.
Table 1. Characteristics of the study population.
No. Percent
Sex 
Male 134 38.1
Female 218 61.9
Age group (years)
< 45 168 47.7
≥ 45 184 52.3
BMI category (kg/m2)
< 25 57 16.2
25–29.9 126 35.8
≥ 30 169 48.0
Smoking statusa
Nonsmoker 90 25.6
Smoker 262 74.4
Glucose level (mg/dL)
≤ 125 292 83.0
> 125 60 17.0 
Self-reported diabetes
Yes 65 18.5
No 287 81.5
Medication status
On medication 303 86.1
Not on medication 49 13.9
Diabetesb
Nondiabetic 281 79.8
Diabetic 71 20.2
aHaving smoked > 100 cigarettes over lifetime. bBased on
either taking antidiabetic drugs or having a serum fasting
glucose of ≥ 125 mg/dL. 
Table 2. Distribution of serum glucose, age, BMI, and lipid measurements among study participants.
Median Mean ± SD Range
Glucose (mg/dL) 94 110.3 ± 48.0 69–480
Age (years) 45.6 48.8 ± 13.2 30.1–84.8
BMI (kg/m2) 29.7 30.5 ± 6.4 15.7–59.8
Cholesterol (mg/L) 196 198.9 ± 38.0 101–306
Triglycerides (mg/L) 137 158.5 ± 95.2 41–746
Lipid (mg/L)a 659 672.4 ± 151.2 372.1–1416.7
aEstimated total lipid based on direct measurement of serum total cholesterol and triglycerides. diabetes among individuals living near haz-
ardous waste sites, particularly if those sites
contain persistent organic pollutants. Perhaps
most compelling are the recent reports of Lee
et al. (2006, 2007) and Everett (2006), who
demonstrated dose–response relationships
between serum concentrations of different
organochlorine compounds and the preva-
lence of diabetes. Lee et al. (2006) included
PCB-153 (one of the phenobarbital-inducer
PCBs), and DDE, as well as two dioxins and
two other pesticides. In an editorial concern-
ing this publication, Porta (2006) noted that
Lee et al. (2006) did not find an association
between obesity and diabetes in individuals
with nondetectible levels of organochlorines.
This raises the surprising possibility that the real
relationship to diabetes is with organochlorine
levels, and that the apparent relationship with
obesity simply reﬂects greater consumption of
animals fats. Everett et al. (2006) found ele-
vated ORs for diabetes with both PCB-126 (a
dioxin-like congener) and p,p´-DDT, but not
with a hexachlorodioxin. In the most recent
analysis of Lee et al. (2007), the relationship to
diabetes was much larger for the sum of four
dioxin-like PCBs than for the sum of three
dioxins, the sum of three furans, the sum of ﬁve
nondioxin-like PCBs, or the sum of four
organochlorine pesticides. In that article, Lee
et al. considered PCB-74 to be a dioxin-like
congener even though it has not been assigned
dioxin toxic equivalents. However, the relation-
ship they observed is consistent with our obser-
vations that PCB-74 showed a stronger
relationship to diabetes than did PCB-153,
which is one of their nondioxin-like congeners.
With respect to HCB, our results are con-
sistent with those reported by Glynn et al.
(2003) and Langer et al. (2007). Glynn et al.
(2003) found a signiﬁcantly higher concen-
tration of HCB in women with diabetes than
in women without the disease. Langer et al.
(2007) reported higher proportions of
impaired fasting glucose among subjects from
high pollution areas with high serum concen-
trations of PCB, DDE, and HCB.
We have not found any published reports
on the relationship between mirex concentra-
tion and diabetes or impaired glucose regula-
tion in humans. Rogers et al. (1984) reported
a steep decrease in plasma glucose levels in
mirex-treated rat fetuses. However, Ervin and
Yarbrough (1985) found no effect of mirex
on plasma glucose levels of hypophysec-
tomized rats. Keller et al. (2004) observed a
statistically nonsignificant negative correla-
tion between the mirex concentration in adi-
pose tissue of live sea turtles and plasma
glucose, as well as a negative association
between whole blood mirex concentration
and plasma glucose. Our observation that
mirex concentrations were inversely related to
diabetes is therefore of interest.
The present study has several limitations.
Only single measurements were made of both
fasting-glucose level and levels of serum PCBs
and pesticides. Although participants were
instructed to fast overnight before providing
blood samples, it could not be objectively con-
ﬁrmed that they did so, and glucose can vary
significantly in the nonfasting state. If some
participants did not fast as instructed, measure-
ment bias could affect our ﬁndings. However,
this bias is likely to be nondifferential because
there is no reason to suppose that participants
with a higher toxicant burden would have been
preferentially more inclined not to fast.
Although the associations are signiﬁcant and
the ORs are high, the 95% conﬁdence inter-
vals are large. This may be due to the limited
number of participants who had an outcome
in the lowest tertile, which was the reference
category of exposure.
Our method for measurement of serum
PCBs gives information on 101 congeners, but
it does not include some of the most potent
dioxin-like congeners, such as PCB-126.
Therefore, we have incomplete information on
the dioxin-like activity. We do not have direct
measurement of total serum lipids, only of
total cholesterol and triglycerides, with applica-
tion of the formula developed by Phillips et al.
(1989) to estimate total serum lipids. Although
widely used, this formula was extrapolated
from a study with a relatively small number of
participants who differed from our study pop-
ulation in ethnicity, sex, and age distribution.
The cross-sectional design of our study
does not permit an assessment of the temporal-
ity of events; that is, we cannot know whether
diabetes results from elevated toxicant levels or
vise versa. Longnecker (2006) raised the possi-
bility that pharmacokinetic variability may
explain the associations observed between
organochlorines and diabetes at background
levels of exposure. He cited the lack of positive
ﬁndings from occupational cohort studies in
which individuals were exposed to much
higher toxicant concentrations and suggested
that at background levels serum concentrations
might reﬂect clearance factors that are related
to risk of diabetes through diet or other innate
factors in addition to intake.
There are also major strengths to our
study. The outcome definition was compre-
hensive on the basis of fasting plasma glucose
values as well as information on the taking of
antidiabetes medication. It is notable that all
of the participants who were under anti-
diabetes treatment responded that they had
been diagnosed with diabetes, which suggests
that misclassification of disease was not an
important issue. Our organochlorine determi-
nations were performed at one time point
using the same analytical methods, which
minimizes the potential for measurement bias.
Our analytical method monitors more PCB
congeners than previous investigations, as well
as three pesticides. The relationships observed
were similar whether contaminant levels were
expressed as wet weight or on a lipid basis, and
demonstrate strong consistency.
We conﬁrmed the information on the dia-
betes diagnosis by the recollection of anti-
diabetes treatment, as well by blood-glucose
measurements. Logistic regression analysis con-
sidering different outcome deﬁnitions (having
PCBs, pesticides, and diabetes
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Table 4. Association between diabetes and serum concentrations of total PCBs, PCB-153, PCB-74, mirex,
HCB, and DDE, adjusted for certain diabetes risk factors.a
Wet-weight measurement  Lipid-standardized measurement
Unadjusted for Concurrent adjustment Unadjusted for  Concurrent adjustment
the other analytesb for the other analytesb the other analytesb for the other analytesb
Analyte OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Total PCBs (ppb)
Medium tertile 2.2 (0.8–5.9) 1.8 (0.6–5.5) 1.8 (0.8–4.3) 1.5 (0.6–4.0)
Highest tertile 3.9 (1.5–10.6) 2.8 (0.7–10.8) 3.2 (1.4–7.5) 2.6 (0.8–8.1)
Mirex (ppb)
Medium tertile  1.2 (0.5–2.7) 0.7 (0.3–1.7) 0.8 (0.3–2.0) 0.6 (0.3–1.4)
Highest tertile  1.0 (0.4–2.2) 0.3 (0.1–0.8) 0.9 (0.4–2.2) 0.3 (0.1–0.9)
DDE (ppb)
Medium tertile 1.8 (0.6–5.2) 1.4 (0.4–4.3) 2.4 (0.7–8.3) 1.6 (0.5–4.8)
Highest tertile 6.4 (2.2–18.4) 2.6 (0.8–8.8) 6.2 (1.8–21.9) 2.4 (0.7–8.3)
HCB (ppb)
Medium tertile 0.9 (0.3–2.7) 0.9 (0.3–2.6) 2.7 (0.9–8.0) 2.5 (0.9–6.8)
Highest tertile 6.2 (2.3–16.9) 4.5 (1.4–14.3) 6.8 (2.3–20.3) 4.8 (1.7–13.9)
PCB-153 (ppb)
Medium tertile 1.0 (0.4–2.5) 0.8 (0.2–2.4) 1.0 (0.4–2.3) 0.6 (0.2–1.6)
Highest tertile 3.2 (1.3–8.2) 3.0 (0.7–12.8) 2.4 (1.0–5.6) 1.4 (0.4–4.8)
PCB-74 (ppb)
Medium tertile 1.3 (0.4–3.7) 1.3 (0.4–4.4) 1.3 (0.3–4.7) 0.9 (0.3–3.0)
Highest tertile 4.9 (1.7–13.7) 3.6 (1.0–13.4) 4.5 (1.3–15.6) 2.9 (0.8–10.5)
CI, conﬁdence interval.
aAll ORs were adjusted for sex, age category, BMI category, and lifetime smoking status; in addition, wet-weight values
were adjusted for estimated total lipid concentration. bOther analytes included serum concentrations of DDE, HCB, and
mirex for total PCBs, PCB-153, and PCB-74; total PCBs, DDE, and HCB for mirex; total PCBs, mirex, and HCB for DDE; and
total PCBs, mirex, and DDE for HCB. diabetes as diagnosed by a physician, being on
antidiabetes medication, or having fasting
plasma glucose values > 125 mg/dL, each
assessed separately) yielded similar ﬁndings in
terms of significant association between
increased organochlorine exposure and occur-
rence of diabetes.
In our analysis we controlled for other
known or possible risk factors for diabetes. As
expected, age is a signiﬁcant risk factor. BMI
also proved to be a significant risk factor,
which is consistent with previously reported
associations between diabetes and obesity [Hu
et al. 2001; Kriska et al. 2003; but see Porta
(2006)]. Total serum lipid levels were mod-
estly related to risk of diabetes. Smoking has
been reported to be a risk factor for diabetes
(Rimm et al. 1995; Will 2001). However,
smoking, defined as having smoked at least
100 cigarettes in the lifetime, was not found to
be signiﬁcantly associated with diabetes. There
was no signiﬁcant difference by sex, which is
consistent with the ﬁnding in national studies
(CDC 2003b). We did not control for diet,
exercise, or physical activity.
Diabetes prevalence in our study popula-
tion (22.4% in men and 18.4% in women)
was slightly higher than that reported for
other Native-American and Alaska Native
populations adjusted for age (CDC 2003a;
Burrows et al. 2000). In a previous study of
clinic patients from the same community,
Negoita et al. (2001) found a prevalence of
diabetes ranging from 2.9% in subjects
30–44 years of age to 21.3% in those
> 75 years of age. We found a higher propor-
tion of persons with diabetes across all age
groups, which is partially explained though
the identiﬁcation of individuals with elevated
blood-glucose levels not previously diagnosed
with diabetes.
Because PCBs are very persistent in the
human body, fasting serum levels provide
some indication of lifetime exposure, even
though some congeners are more persistent
than others. Although the serum PCB levels in
this population (mean of 5.0 ppb) are some-
what higher than in the general population
that does not have particular exposure
[reported by the Agency for Toxic Substances
and Disease Registry (ATSDR) (2000) to be
0.9–1.5 ppb], the range of PCB levels
(0.51–48.32 ppb) in adult Mohawks includes
background levels found in the general popula-
tion. For comparison on the basis of a single
congener, Lee et al. (2006) reported the con-
centration of PCB-153 in their study to be
36.7 ng/g lipid in the 25th–50th percentile,
and 60.2 ng/g lipid in the 50th–75th per-
centile, whereas in our Mohawk population
the values were 78.3 ng/g lipid at the 50th per-
centile and 104.4 ng/g lipid at the 67th per-
centile. The demonstration of the association
between levels of total PCBs, DDE, and HCB
with diabetes (almost certainly type 2) is
consistent with the results of previous investi-
gations and provides additional evidence that
this relationship occurs among different eth-
nicities and populations.
We found statistically significant eleva-
tions in risk of diabetes for total PCBs, the
two PCB congeners reported separately, and
DDE and HCB. The most elevated ORs were
found for HCB, both before and after adjust-
ment for other analytes. Although the lower
bound of the 95% confidence limit after
adjustment for other analytes did not exceed
1.0 for total PCBs, PCB-74, PCB-153, and
DDE, the ORs were elevated. However, it
must be recognized that all PCBs and chlori-
nated pesticides are fat-soluble substances,
which means that they migrate together.
Therefore, caution must be taken in drawing
conclusions on the question of which sub-
stances are more important in explaining the
relationships observed.
The biochemical mechanisms underlying
the relationship between diabetes and serum
levels of organochlorines are still uncertain. In
animal studies, morphologic changes have
been reported in the structure of beta cells in
the pancreas upon PCB exposure (Kimbrough
et al. 1972; Wassermann et al. 1975), and
altered expression of gluconeogenic enzymes
were found in rat liver (Boll et al. 1998). HCB
has been reported to disrupt the gluconeo-
genic pathways in animal models (Mazzetti
et al. 2004), and it is possible that other
organochlorines have similar actions. Other
potential mechanisms involve the organochlo-
rine impacts on the immune system (Langer
et al. 2002), as well as a dioxin-like action on
insulin regulation, an action that may be
mediated through sex-hormone binding glob-
ulin, as suggested by Michalek et al. (1999).
PCBs induce several different cytochrome
P450s in the liver and other tissues (Bandiera
2001); this results in unique patterns of gene
induction (Vezina et al. 2004). We suspect
that if these relationships are ultimately found
to be causative, the explanation will come
from the gene induction that results from
exposure to substances that are metabolized by
cytochrome P450s.
Conclusion
In this cross-sectional study, serum concentra-
tions of total PCBs, two single PCB con-
geners, DDE, and HCB were positively
associated with an elevated incidence of dia-
betes in an adult Native-American population.
These ﬁndings are consistent with the hypoth-
esis that exposure to organochlorine com-
pounds increases the risk of developing
diabetes. A negative association was found
between the serum concentration of mirex and
diabetes. This ﬁnding has not been previously
reported and merits further investigation.
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